Fundraising Fox

Applied DNA Sciences

Stony Brook, US · Founded 2008 · Delaware corporation · 47 employees on LinkedIn

Biotech

Founders & leadership

JA
James A. HaywardChairman of the Board, CEO and President
CS
Clay ShorrockExecutive
BJ
Beth JantzenChief Financial Officer
JM
Judith MurrahExecutive
ML
Ming-Hwa LiangChief Technology Officer and Secretary
MB
MING-HWA BENJAMIN LIANGNamed on SEC filing
JB
JOHN BITZER, IIINamed on SEC filing
KG
KAROL GRAYNamed on SEC filing
JM
Judy MurrahNamed on SEC filing
JA
JAMES A HAYWARDNamed on SEC filing
SR
SANFORD R. SIMONNamed on SEC filing
YS
YACOV SHAMASHNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$75M disclosed across 11 of 13 rounds · 2014–2026

▶$2.5MraisedJun 2026 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Joshua KrugerDirector
  • Clay D. ShorrockExecutive Officer
  • Judith MurrahDirector
  • James HaftDirector
  • Robert B. CatellDirector
  • Yacov A. ShamashDirector
  • Beth M. JantzenExecutive Officer
  • Joseph D. CeccoliDirector
Offering amount
$5M
Amount sold
$2.5M
First sale
May 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$58MraisedOct 2025 · 33 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert B. CatellDirector
  • Clay ShorrockExecutive Officer
  • Beth JantzenExecutive Officer
  • Joseph D. CeccoliDirector
  • Judith MurrahExecutive Officer, Director
  • Yacov A. ShamashDirector
  • Elizabeth M. Schmalz ShaheenDirector
Offering amount
$58M
Amount sold
$58M
Sales commissions
$361.7K
Proceeds to insiders
$725K
Placement agents
Lucid Capital Markets, LLC
First sale
Sep 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13.3MofferedNov 2024 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph D. CeccoliDirector
  • Elizabeth M. Schmalz ShaheenDirector
  • Sanford R. SimonDirector
  • James A. HaywardExecutive Officer, Director
  • Yacov ShamashDirector
  • Clay ShorrockExecutive Officer
  • Beth JantzenExecutive Officer
  • Robert B. CatellDirector
  • Judith MurrahExecutive Officer
Offering amount
$13.3M
Sales commissions
$490K
Placement agents
Craig-Hallum Capital Group LLC
First sale
Oct 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.9MofferedFeb 2024 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph D. CeccoliDirector
  • Clay ShorrockExecutive Officer
  • Sanford R. SimonDirector
  • Robert B. CatellDirector
  • James A. HaywardExecutive Officer, Director
  • Yacov A. ShamashDirector
  • Beth JantzenExecutive Officer
  • Elizabeth M. Schmalz ShaheenDirector
  • Judith MurrahExecutive Officer
Offering amount
$6.9M
Sales commissions
$273.4K
Placement agents
Maxim Group LLC
First sale
Feb 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedOct 2020 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James A. HaywardExecutive Officer, Director
  • Beth JantzenExecutive Officer
  • Judith MurrahExecutive Officer
  • John Bitzer, IIIDirector
  • Elizabeth M. Schmalz FergusonDirector
  • Joseph D. CeccoliDirector
  • Scott AnchinDirector
  • Sanford R. SimonDirector
  • Yacov A. ShamashDirector
  • Robert B. CatellDirector
Offering amount
$3.7M
Amount sold
$1.2M
First sale
Oct 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$418KraisedAug 2019 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Elizabeth M. Schmalz FergusonDirector
  • Yacov A. ShamashDirector
  • Sanford R. SimonDirector
  • Charles S. RyanDirector
  • Robert B. CatellDirector
  • James A. HaywardExecutive Officer, Director
  • Beth JantzenExecutive Officer
  • Judith MurrahExecutive Officer
  • John Bitzer, IIIDirector
  • Joseph D. CeccoliDirector
Offering amount
$418K
Amount sold
$418K
First sale
Aug 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedJul 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James A. HaywardExecutive Officer, Director
  • Beth JantzenExecutive Officer
  • Judith MurrahExecutive Officer
  • John Bitzer, IIIDirector
  • Robert B. CatellDirector
  • Joseph D. CeccoliDirector
  • Charles S. RyanDirector
  • Sanford R. SimonDirector
  • Yacov A. ShamashDirector
  • Elizabeth M. Schmalz FergusonDirector
Offering amount
$1.5M
Amount sold
$1.5M
First sale
Jul 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.6MraisedSep 2018 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Judith MurrahExecutive Officer
  • Beth JantzenExecutive Officer
  • James A. HaywardExecutive Officer, Director
Offering amount
$3.5M
Amount sold
$1.6M
First sale
Aug 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Applied DNA announces $6.5 million securities offering By Investing.cominvesting.com · Oct 2024Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement | APDN Stock Newsstocktitan.net · Oct 2024Applied DNA Sciences, Inc. Raises $1.8 Million In Private Placement Led By Executive Officers, Board Members And Strategic Investor - BioSpacebiospace.com · Jun 2017Applied DNA Sciences Inc. fights counterfeits with DNA – The Statesmansbstatesman.com

Frequently asked questions

How much funding has Applied DNA Sciences raised?
Applied DNA Sciences has disclosed $75M raised across 11 of its 13 known rounds.
Where is Applied DNA Sciences headquartered?
Applied DNA Sciences is headquartered in Stony Brook, US.